224 research outputs found

    High-temperature creep strength and room-temperature fracture toughness of MoSiBTiC alloy

    Get PDF
    Quite recently, the author and his coworkers have developed a new high-temperature material based on Mo-Si-B alloys with TiC addition for ultrahigh temperature applications. The alloys are produced not by powder sintering but by casting, and the constituent phases are of Mo solid solution, Mo5SiB2 (T2), (Ti, Mo)C and (Mo, Ti)2C. The density is reduced to less than 9.0 g/cm3, which is comparable to that of Ni-base superalloys. The high-temperature compressive strength is much stronger than that of commercial heat-resistant molybdenum alloys such as TZM and MHC in a wide high-temperature range. In this paper, the recent progress of our research and development of the MoSiBTiC alloys is reviewed focusing on high-temperature creep strength and room temperature fracture toughness. The alloy having a primary phase during solidification of (Ti, Mo)C and thus a higher (Ti, Mo)C volume fraction was examined for tensile creep properties, and it was found that the alloy showed typical tensile creep curves accompanying transient, steady-state and acceleration creep stages in all the test conditions. The creep strength was relatively good, for example, the rupture time at 1350 °C under 170 MPa was about 750 h. The stress exponents, n, in the temperature range of 1400 – 1600 °C and the stress range of 100 – 300 MPa were ≈ 3 while it was 5 – 6 at 1350 °C, suggesting that the rate-controlling process of creep deformation is different between at and below 1350 °C and at and above 1400 °C in the stress range. Room-temperature fracture toughness of the MoSiBTiC alloys was measured by three-point or four-point bending tests using Chevron-notched specimens. The alloy having the primary phase of (Ti, Mo)C showed the fracture toughness value of better than 15 MPa(m)1/2 at room temperature. The value was better than that of the alloy having a primary phase of Moss and thus a higher Moss volume fraction. The obtained results indicated that (Ti, Mo)C phase works for improving not only high-temperature strength but also room-temperature fracture toughness

    Dietary Modification of Mouse Response to Total-Body-Irradiation

    Get PDF
    Exposure to ionizing radiation (IR) could induce deleterious effects including cancer. Diet, as one of the major factors to influence susceptibility to many diseases, plays a critical role in maintaining human heath. It is known that unbalanced diet could result in health consequences, for example, high-calorie diet could lead to obesity, which could increase the risk of diabetes, heart disease, fatty liver, and some forms of cancer. Although the impact of diet on susceptibility to IR is thought to be big, the evidence is not clear due to lack of study. In this work, effects from dietary fat on modulation of mouse responses to total-body-irradiation (TBI) were studied. The mice were fed after weaning at postnatal age of 4 weeks with a standard diet (MB-1), a very high-fat diet (HFD32), and a very low-fat diet (CE-2 Low Fat), containing of 4.4%, 32.0%, and 0.4% of crude fat, respectively. A mouse model for radiation-induced adaptive response (AR) was applied to this work. The priming low-dose TBI at a dose of 0.5 Gy from X-rays was given at postnatal age of 6 weeks, and the challenge high dose of TBI was given at postnatal age of 8 weeks. The mouse response to low dose of TBI was evaluated by the efficacy of the priming low dose to rescue the animals from bone marrow death induced by the challenge high dose in the 30-day survival test. The mouse response to high dose of TBI was evaluated by comparing the LD50 in the 30-day survival test. In addition, dietary modulation of the residual (late) genotoxic effect from TBI was also evaluated by comparing the incidence of micronucleated erythrocytes in bone marrow using micronucleus test. Results showed that for the mice fed with the MB-1, a successful AR was demonstrated. While for the mice fed with either HFD32 or CE-2 Low Fat, no AR was observed, and all the animals died within 15 days after TBI with the challenge high dose at 7.5 Gy regardless the priming low dose at 0.5 Gy. When comparing the LD50 in the 30-day survival test, the LD50 values for the animals fed with the MB-1, HFD32 diet, and CE-2 Low Fat were 7.1 Gy, 6.0 Gy, and 6.2 Gy, respectively. As to the micronucleus test, for the mice fed with MB-1, the priming low dose at 0.5 Gy could significantly reduce the incidence of micronucleated erythrocytes in bone marrow that were caused by a challenge high dose at 4.0 Gy, while for the mice fed with either HFD32 or CE-2 Low Fat no such effect was observed. These findings indicated that under an unbalanced diet, namely, either of very high fat or of very low fat, alterations in mouse responses to TBI were induced. These findings confirmed that diet played a pivotal role in the response of the animals to radiation exposure, and suggested the possibility to modulate radiosensitivity through diet intervention in humans

    Time-dependent approach to many-particle tunneling in one-dimension

    Full text link
    Employing the time-dependent approach, we investigate a quantum tunneling decay of many-particle systems. We apply it to a one-dimensional three-body problem with a heavy core nucleus and two valence protons. We calculate the decay width for two-proton emission from the survival probability, which well obeys the exponential decay-law after a sufficient time. The effect of the correlation between the two emitted protons is also studied by observing the time evolution of the two-particle density distribution. It is shown that the pairing correlation significantly enhances the probability for the simultaneous diproton decay.Comment: 9 pages, 10 eps figure

    Diallyl Disulfide Mitigates DNA Damage and Spleen Tissue Effects After Irradiation

    Get PDF
    BACKGROUND Several factors found in foods are beneficial to human health and they may contribute to radiation protection. Taking food factors could be an easy way to reduce the effects of radiation after nuclear accidents, as well as secondary radiation risks after cancer radiotherapy or space missions. Here, diallyl disulfide (DADS), a component of garlic oil, was studied for its ability to mitigate radiation damage. MATERIAL AND METHODS We investigated the effects of DADS on micronucleus (MN) formation and apoptosis in HepG2 cells by use of 4-Gy X-ray irradiation. We also assessed the effects of DADS on radiation damage in vivo by evaluating MN formation in bone marrow cells in mice (BALB/c, 8-week-old females) after oral intake of DADS prior to irradiation with 4 Gy. Several tissue effects were also investigated. RESULTS The presence of DADS inhibited MN formation, whereas DADS had no influence on the radiation-induced inhibition of cell cycle progression in HepG2 cells. An increase in apoptosis in HepG2 cells was induced after irradiation, and this effect was stronger in the presence of DADS than in its absence. In mice, when DADS was administered daily for 3 days prior to irradiation, MN formation in irradiated mice was decreased. The decrease in MN formation in mice was greater with 0.5% DADS compared to 1% DADS. Moreover, an increase in spleen weight observed 3 weeks after irradiation was suppressed in mice administered DADS. CONCLUSIONS DADS is a potential radiation-protective agent that effectively mitigates DNA damage, and its effects in the spleen observed after irradiation may be related to inflammation and carcinogenesis

    A study on the scattering exposure dose in radiotherapy.

    Get PDF
    現代の医療のなかで癌治療において不可欠な存在となった放射線治療。一方,放射線被曝はたとえわずかであってもリスクが伴い,厳しく規制されている。ただし医療被曝はこの限りになく,過去においては癌患者に放射線治療をおこなう際の患部以外の被曝についてはあまり問題視されなかった。これには癌の治療という前提に加え,長期生存の可能性が低く,存命中に晩発障害が発生することが低いと考えられていたからである。しかし,集学的治療が確立した今後の放射線治療においては完治する放射線治療患者が多くなり,治癒後の余命が長くなることが予測される。放射線被曝による確率的影響は閾値がなく,影響は当然現れるであろう。そこで,放射線治療をおこなう際の患者の散乱線被曝線量,治療室内散乱線量,さらに高エネルギー放射線発生装置を取り扱うときに問題となっている中性子を測定した。その結果,測定線量は治療患部外被曝,室内散乱線量ともに無視できない量であることがわかった。中性子については,人体に影響がある線量は検出されなかったが,中性子の存在は室内物品の放射化の可能性を示唆するもので定期的な測定管理が必要である。また,Ⅹ線撮影室用の防護衣による散乱線被曝の低減効果は放射線治療室では無意味であった。In modern medicine, radiotherapy has proved indispensable in the treatment of cancer. However. radiation exposure is a health hazard. and is thus strictly regulated. In the past, incidental exposure was not considered to pose a considerable risk, and because radiotherapy was an effective treatment for cancer and because the possibility of the long-term survival was generally poor, the prevalence of radiation injury was thought to be low. In recent years, however, more patients are making complete recoveries, and it is believed that long-term survival is possible with future radiotherapy techniques. There is no threshold for the stochastic effects of radiation exposure, and thus such effects may be detected even at low levels. In the present study, we measured the radiation exposure due to scattered rays from the patient, incidental radiation levels in the radiotherapy room, and levels of neutron radiation. which is a problem when high-energy X-ray radiotherapy systems are used. The results showed that exposure due to scattered rays and incidental levels in the radiotherapy room cannot be dismissed. and that further investigation is warranted. As for neutron radiation, dosages were below those that are known to influence the human body, but regular measurement is necessary because it may induce radioactivity in otherwise benign equipment. In addition, a protective apron had no effect on the exposure due to scattered rays in the radiotherapy room

    Altered Response to Total Body Irradiation of C57BL/6-Tg (CAG-EGFP) Mice

    Get PDF
    Application of green fluorescent protein (GFP) in a variety of biosystems as a unique bioindicator or biomarker has revolutionized biological research and made groundbreaking achievements, while increasing evidence has shown alterations in biological properties and physiological functions of the cells and animals overexpressing transgenic GFP. In this work, response to total body irradiation (TBI) was comparatively studied in GFP transgenic C57BL/6-Tg (CAG-EGFP) mice and C57BL/6 N wild type mice. It was demonstrated that GFP transgenic mice were more sensitive to radiation-induced bone marrow death, and no adaptive response could be induced. In the nucleated bone marrow cells of GFP transgenic mice exposed to a middle dose, there was a significant increase in both the percentage of cells expressing pro-apoptotic gene Bax and apoptotic cell death. While in wild type cells, lower expression of pro-apoptotic gene Bax and higher expression of anti-apoptotic gene Bcl-2, and significant lower induction of apoptosis were observed compared to GFP transgenic cells. Results suggest that presence of GFP could alter response to TBI at whole body, cellular and molecular levels in mice. These findings indicate that there could be a major influence on the interpretation of the results obtained in GFP transgenic mice

    Synergistic Effects of Chronic Restraint-Induced Stress and Low-Dose 56Fe-particle Irradiation on Induction of Chromosomal Aberrations in Trp53-Heterozygous Mice

    Get PDF
    Astronauts can develop psychological stress (PS) during space flights due to the enclosed environment, microgravity, altered light-dark cycles, and risks of equipment failure or fatal mishaps. At the same time, they are exposed to cosmic rays including high atomic number and energy (HZE) particles such as iron-56 (Fe) ions. Psychological stress or radiation exposure can cause detrimental effects in humans. An earlier published pioneering study showed that chronic restraint-induced psychological stress (CRIPS) could attenuate Trp53 functions and increase carcinogenesis induced by low-linear energy transfer (LET) γ rays in Trp53-heterozygous (Trp53+/–) mice. To elucidate possible modification effects from CRIPS on high-LET HZE particle-induced health consequences, Trp53+/– mice were received both CRIPS and accelerated Fe ion irradiation. Six-week-old Trp53+/– C57BL/6N male mice were restrained 6 h per day for 28 consecutive days. On day 8, they received total-body Fe-particle irradiation (Fe-TBI, 0.1 or 2 Gy). Metaphase chromosome spreads prepared from splenocytes at the end of the 28-day restraint regimen were painted with the fluorescence in situ hybridization (FISH) probes for chromosomes 1 (green), 2 (red) and 3 (yellow). Induction of psychological stress in our experimental model was confirmed by increase in urinary corticosterone level on day 7 of restraint regimen. Regardless of Fe-TBI, CRIPS reduced splenocyte number per spleen at the end of the 28-day restraint regimen. At 2 Gy, Fe-TBI alone induced many aberrant chromosomes and no modifying effect was detected from CRIPS on induction of aberrant chromosomes. Notably, neither Fe-TBI at 0.1 Gy nor CRIPS alone induced any increase in the frequency of aberrant chromosomes, while simultaneous exposure resulted in a significant increase in the frequency of chromosomal exchanges. These findings clearly showed that CRIPS could enhance the frequency of chromosomal exchanges induced by Fe-TBI at a low dose of 0.1 Gy

    J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan

    Get PDF
    The Japan Chronic Kidney Disease (CKD) Database (J-CKD-DB) is a large-scale, nation-wide registry based on electronic health record (EHR) data from participating university hospitals. Using a standardized exchangeable information storage, the J-CKD-DB succeeded to efficiently collect clinical data of CKD patients across hospitals despite their different EHR systems. CKD was defined as dipstick proteinuria ≥1+ and/or estimated glomerular filtration rate <60 mL/min/1.73 m² base on both out- and inpatient laboratory data. As an initial analysis, we analyzed 39, 121 CKD outpatients (median age was 71 years, 54.7% were men, median eGFR was 51.3 mL/min/1.73 m²) and observed that the number of patients with a CKD stage G1, G2, G3a, G3b, G4 and G5 were 1, 001 (2.6%), 2, 612 (6.7%), 23, 333 (59.6%), 8, 357 (21.4%), 2, 710 (6.9%) and 1, 108 (2.8%), respectively. According to the KDIGO risk classification, there were 30.1% and 25.5% of male and female patients with CKD at very high-risk, respectively. As the information from every clinical encounter from those participating hospitals will be continuously updated with an anonymized patient ID, the J-CKD-DB will be a dynamic registry of Japanese CKD patients by expanding and linking with other existing databases and a platform for a number of cross-sectional and prospective analyses to answer important clinical questions in CKD care

    Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)

    Get PDF
    Background: The Japan Chronic Kidney Disease Database (J-CKD-DB) is a nationwide clinical database of patients with chronic kidney disease (CKD) based on electronic health records. The objective of this study was to assess the prevalence of anemia and the utilization rate of erythropoiesis-stimulating agents (ESAs) in Japanese patients with CKD. Methods: In total, 31, 082 adult outpatients with estimated glomerular filtration rates of 5–60 ml/min/1.73 m2 in seven university hospitals were included this analysis. The proportions of patients with CKD stages G3b, G4, and G5 were 23.5%, 7.6%, and 3.1%, respectively. Results: The mean (standard deviation) hemoglobin level of male patients was 13.6 (1.9) g/dl, which was significantly higher than the mean hemoglobin level of female patients (12.4 (1.6) g/dl). The mean (standard deviation) hemoglobin levels were 11.4 (2.1) g/dl in patients with CKD stage G4 and 11.2 (1.8) g/dl in patients with CKD stage G5. The prevalences of anemia were 40.1% in patients with CKD stage G4 and 60.3% in patients with CKD stage G5. Logistic regression analysis showed that diagnoses of CKD stage G3b (adjusted odds ratio [95% confidence interval]: 2.32 [2.09–2.58]), G4 (5.50 [4.80–6.31]), and G5 (9.75 [8.13–11.7]) were associated with increased prevalence of anemia. The utilization rates of ESAs were 7.9% in patients with CKD stage G4 and 22.4% in patients with CKD stage G5. Conclusions: We determined the prevalence of anemia and utilization rate of ESAs in Japanese patients with CKD using data from a nationwide cohort study
    corecore